Results
1 -
10 of
158K. Abrahamsson, P. Andersson, J. Bergman, U. Bredberg, J. Brånalt, A.-C. Egnell, et al..
2 Vitamin K deficiency amplifies anticoagulation response to ximelagatran: possible implications for direct thrombin inhibitors and their clinical safety, Annals of Hematology Off-Label-Use in der Langzeitantikoagulation nach Lebertransplantation wegen phenprocoumoninduzierten Leberversagens, Medizinische Klinik Genetics of Immune-Mediated Adverse Drug Reactions: a Comprehensive and Clinical Review, Clinical Reviews in Allergy & Immunology Pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran co-administered with different classes of antibiotics in healthy volunteers, European Journal of Clinical Pharmacology No Influence of Food on the Pharmacokinetics, Pharmacodynamics or Tolerability of the 24mg and 36mg Oral Tablet Formulations of Ximelagatran, Clinical Drug Investigation Randomized clinical stroke trials in 2003, Current Atherosclerosis Reports Case Study: Ximelagatran: A Double Prodrug of Melagatran, Prodrugs Oral Antithrombin Agents: Will They Replace Warfarin?, Cardiac Arrhythmias 2005